Clinical research program — current studies

The UC Davis Vascular Center clinical research program is dedicated to contributing to the science of vascular disease through clinical trials. The center's research program is comprehensive and specifically designed to find better, safer ways to treat patients with peripheral arterial disease, also known as PAD. Offering national and innovative clinical trials is one of the many ways that UC Davis helps advance medicine worldwide.

Here are current and upcoming studies focusing on investigational therapies and devices:

Aortic disease and injury

Ovation Study
A pivotal clinical study to evaluate the safety and effectiveness of the Ovation Abdominal Stent Graft System.

TAG Study
Evaluation of the Gore Conformable TAG Thoracic Endoprosthesis for treating traumatic transaction.

Priceless Study
Pressure and imaging—using the Cardiomems Endosure Sensor for long-term follow-up after EVAR with standard surveillance.

Carotid artery disease

CHOICE Study
The RX Acculink/RX Accunet or the Xact/Emboshield carotid artery stent registry study.

SAPPHIRE WW Study
Carotid artery stent registry with the Cordis PRECISE Nitinol Stent System and the Cordis Angioguard XP Emboli Capture Guidewire.

Venous thromboembolism and platelet function

RETRIEVE II Study
Biomedical evaluation of the Crux Inferior Vena Cava Filter System.

Resist PAD Study
The effects of aspirin and thienopyridine non-responsiveness on outcomes in peripheral artery disease.

New treatments and novel technologies for arterial disease

MarrowStim Study
Use of the MarrowStim PAD Kit for treating critical limb ischemia in subjects with severe peripheral arterial disease.

Zen Study
The Medtronic Zotarolimus-Eluting Peripheral Stent System for treating erectile dysfunction in males with sub-optimal response to PDE5 inhibitors.

FMD Registry

The aim of the fibromuscular dysplasia (FMD) registry is to document important medical details of patients with FMD in order to help understand more about FMD.  We believe this information will help improve the treatment of patients with FMD in the future. For more information on FMD visit the Fibromuscular Dysplasia Society of America website: http://fmdsa.prod.cgalvin.com.

For more information
To find out if one of these studies is right for you, please call Christy Pifer, the vascular center's clinical research coordinator, at 916-734-4156.